Exploring the molecular classification-based personalized treatment decision-making in FIGO stage I–III endometrial carcinoma after surgery: a population-based real-world study
Therapeutic Advances in Medical Oncology
Published online on June 26, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Robust real-world evidence supporting the clinical utility of molecular classification in endometrial carcinoma (EC) remains limited.Objectives:To investigate the molecular classification-based personalized treatment decision-making for EC by ...
Background:Robust real-world evidence supporting the clinical utility of molecular classification in endometrial carcinoma (EC) remains limited.Objectives:To investigate the molecular classification-based personalized treatment decision-making for EC by ...